WS11.5 Evaluation of combinations of the CFTR potentiator dirocaftor, corrector posenacaftor and amplifier nesolicaftor in cystic fibrosis subjects with two copies of the F508del mutation - Downey, D. G; Fajac, I.; Flume, P.; O’Carroll, M.; Pressler, T.; Proesmans, M.; Quon, B.; Schwarz, C.; Sutharsan, S.; Jiang, J.; Gilmartin, G. (Journal of cystic fibrosis, 2020)